Literature DB >> 35482859

Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment.

Eran Hodis1,2,3, Elena Torlai Triglia1, John Y H Kwon1,2, Tommaso Biancalani1, Labib R Zakka4,5, Saurabh Parkar1, Jan-Christian Hütter1, Lorenzo Buffoni1, Toni M Delorey1, Devan Phillips1, Danielle Dionne1, Lan T Nguyen1, Denis Schapiro1,6, Zoltan Maliga6, Connor A Jacobson6, Ayal Hendel7, Orit Rozenblatt-Rosen1, Martin C Mihm4,5, Levi A Garraway1,2, Aviv Regev1,8.   

Abstract

Establishing causal relationships between genetic alterations of human cancers and specific phenotypes of malignancy remains a challenge. We sequentially introduced mutations into healthy human melanocytes in up to five genes spanning six commonly disrupted melanoma pathways, forming nine genetically distinct cellular models of melanoma. We connected mutant melanocyte genotypes to malignant cell expression programs in vitro and in vivo, replicative immortality, malignancy, rapid tumor growth, pigmentation, metastasis, and histopathology. Mutations in malignant cells also affected tumor microenvironment composition and cell states. Our melanoma models shared genotype-associated expression programs with patient melanomas, and a deep learning model showed that these models partially recapitulated genotype-associated histopathological features as well. Thus, a progressive series of genome-edited human cancer models can causally connect genotypes carrying multiple mutations to phenotype.

Entities:  

Mesh:

Year:  2022        PMID: 35482859      PMCID: PMC9427199          DOI: 10.1126/science.abi8175

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  78 in total

1.  Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.

Authors:  Trine O Jensen; Henrik Schmidt; Holger J Møller; Frede Donskov; Morten Høyer; Pia Sjoegren; Ib J Christensen; Torben Steiniche
Journal:  Cancer       Date:  2011-09-22       Impact factor: 6.860

2.  Dynamics of CRISPR-Cas9 genome interrogation in living cells.

Authors:  Spencer C Knight; Liangqi Xie; Wulan Deng; Benjamin Guglielmi; Lea B Witkowsky; Lana Bosanac; Elisa T Zhang; Mohamed El Beheiry; Jean-Baptiste Masson; Maxime Dahan; Zhe Liu; Jennifer A Doudna; Robert Tjian
Journal:  Science       Date:  2015-11-13       Impact factor: 47.728

3.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

4.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

Review 5.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

6.  CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.

Authors:  Daniel P Dever; Rasmus O Bak; Andreas Reinisch; Joab Camarena; Gabriel Washington; Carmencita E Nicolas; Mara Pavel-Dinu; Nivi Saxena; Alec B Wilkens; Sruthi Mantri; Nobuko Uchida; Ayal Hendel; Anupama Narla; Ravindra Majeti; Kenneth I Weinberg; Matthew H Porteus
Journal:  Nature       Date:  2016-11-07       Impact factor: 49.962

7.  Pan-cancer image-based detection of clinically actionable genetic alterations.

Authors:  Alexander T Pearson; Tom Luedde; Jakob Nikolas Kather; Lara R Heij; Heike I Grabsch; Chiara Loeffler; Amelie Echle; Hannah Sophie Muti; Jeremias Krause; Jan M Niehues; Kai A J Sommer; Peter Bankhead; Loes F S Kooreman; Jefree J Schulte; Nicole A Cipriani; Roman D Buelow; Peter Boor; Nadi-Na Ortiz-Brüchle; Andrew M Hanby; Valerie Speirs; Sara Kochanny; Akash Patnaik; Andrew Srisuwananukorn; Hermann Brenner; Michael Hoffmeister; Piet A van den Brandt; Dirk Jäger; Christian Trautwein
Journal:  Nat Cancer       Date:  2020-07-27

8.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

9.  Emerging landscape of oncogenic signatures across human cancers.

Authors:  Giovanni Ciriello; Martin L Miller; Bülent Arman Aksoy; Yasin Senbabaoglu; Nikolaus Schultz; Chris Sander
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

10.  Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq.

Authors:  Dylan Kotliar; Adrian Veres; M Aurel Nagy; Shervin Tabrizi; Eran Hodis; Douglas A Melton; Pardis C Sabeti
Journal:  Elife       Date:  2019-07-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.